Scholars Central

Research articlePublished 22 Jul 2019

The Efficacy and Safety of Teneligliptin and Metformin versus Glimepiride and Metformin in Patients of Type-2 Diabetes Mellitus Uncontrolled with Monotherapy

Authors: Nitika Hans

Journal of Diabetes & Metabolism

Volume 10 · Issue 6 · Pages 1–9

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: Type 2 diabetes mellitus is one of the most common non-communicable diseases associated with short term and long term complications. Material and methods: A total of 60 patients were included in the study divided into 2 groups of 30 patients each. Group 1 patients were given Teneligliptin 10 mg once a day and metformin 500 mg twice a day after meals for 12 weeks. Group 2 patients were given Glimepiride 1 mg once a day and metformin 500 mg twice a day after meals for 12 weeks. After the written consent, history, clinical examination, biochemical investigations including FBG, PPBG, HbA1c and lipid profile were done. Repeat FBG and PPBG were done every week upto 12 weeks. HbA1c and lipid profile were done at the beginning and at the end of study. Results: Change in FBG was more in group 1 as compared to group 2. On comparison of reduction in change in PPBG in patients of group 1 versus group 2, there was a highly significant reduction in group 1. Change in HbA1c, total cholesterol levels, triglyceride levels, HDL and LDL was more in group 1 than in group 2. Conclusion: Teneligliptin and metformin caused a greater improvement in glycaemic and lipid profile as compared to Glimepiride and metformin. Thus teneligliptin is more efficacious than glimepiride.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Diabetes & Metabolism.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Diabetes & Metabolism
  • SubjectDiabetes & Endocrinology
  • BylineArticles whose byline prints “Nitika Hans”